Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T MacLaughlin

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
The New England Journal of Medicine|February 23, 1992
Müllerian inhibiting substance as a marker for ovarian sex-cord tumorM L Gustafson, M M Lee, R E Scully, et al.
Development (Cambridge, England)|May 5, 1999
The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryoZ Gu, E M Reynolds, J Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
The New England Journal of Medicine|February 23, 1992
Müllerian inhibiting substance as a marker for ovarian sex-cord tumorM L Gustafson, M M Lee, R E Scully, et al.
Development (Cambridge, England)|May 5, 1999
The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryoZ Gu, E M Reynolds, J Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
Pageof 8